Federated Hermes’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $903 | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $138 | Hold |
|
|||||
|
2024
Q2 | $143 | Sell |
|
|||||
|
2024
Q1 | $9.57K | Buy |
|
|||||
|
2023
Q4 | $5.4K | Buy |
|
|||||
|
2023
Q3 | $1.82K | Hold |
|
|||||
|
2023
Q2 | $2.43K | Hold |
|
|||||
|
2023
Q1 | $2.14K | Sell |
|
|||||
|
2022
Q4 | $5.67K | Sell |
|
|||||
|
2022
Q3 | $6K | Buy |
|
|||||
|
2022
Q2 | $7K | Buy |
|
|||||
|
2022
Q1 | $1K | Sell |
|
|||||
|
2021
Q4 | $4.16M | Sell |
|
|||||
|
2021
Q3 | $4.89M | Buy |
|
|||||
|
2021
Q2 | $5.9M | Buy |
|
|||||
|
2021
Q1 | $4.59M | Buy |
|
|||||
|
2020
Q4 | $2.38M | Buy |
|
|||||
|
2020
Q3 | $123K | Buy |
|
|||||
|
2020
Q2 | $57K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $51K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $3.58M | Buy |
|
|||||
|
2017
Q4 | $1.46M | Buy |
|